手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
6条
与
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
有关的结果
Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis COMMENT
2021 年 发布于
Indian J Urol
206 卷 第 6 期
Greco F.
Administration
Intravesical
Antineoplastic Agents/*administration & dosage/adverse effects
Clinical Trials as Topic
Disease Progression
Humans
Neoplasm Metastasis
*Neoplasm Recurrence
Local
Network Meta-Analysis
Progression-Free Survival
Risk Assessment
Risk Factors
Time Factors
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
文献简介
原文链接
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection
2021 年 发布于
World J Urol
2 卷 第 3 期
Veskimae E.
Subbarayan S.
Campi R.
Carron D.
Omar M. I.
Yuan C.
Dimitropoulos K.
Van Hemelrijck M.
Bryan R. T.
N'Dow J.
Babjuk M.
Witjes J. A.
Sylvester R.
MacLennan S.
Adjuvants
Immunologic/administration & dosage
Administration
Intravesical
Antibiotics
Antineoplastic/administration & dosage/adverse effects
Antimetabolites
Antineoplastic/*administration & dosage/adverse effects
BCG Vaccine/administration & dosage
Bias
Cause of Death
Confidence Intervals
Deoxycytidine/administration & dosage/adverse effects/*analogs & derivatives
Disease Progression
Drug Administration Schedule
Humans
Mitomycin/administration & dosage/adverse effects
Neoplasm Recurrence
Local/*drug therapy/mortality/prevention & control
Randomized Controlled Trials as Topic
Saline Solution/administration & dosage
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
/prevention & control
Gemcitabine
文献简介
原文链接
Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis
2021 年 发布于
Transl Androl Urol
30 卷 第 1 期
Deb A. A.
Agag A.
Naushad N.
Krishnamoorthy R.
Serag H.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemotherapy
Adjuvant
*Cystectomy/methods
Humans
Neoadjuvant Therapy
Neoplasm Invasiveness
Survival Rate
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
/*surgery
Muscle-invasive bladder cancer
Neoadjuvant chemotherapy
Overall survival
Radical cystectomy
文献简介
原文链接
Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis
2019 年 发布于
Cancer Management and Research
7 卷 第 4 期
Crozier J.
Papa N.
Perera M.
Ngo B.
Bolton D.
Sengupta S.
Lawrentschuk N.
Administration
Intravesical
Antibiotics
Antineoplastic/*administration & dosage
BCG Vaccine/administration & dosage
Carcinoma in Situ/*drug therapy/mortality/pathology
Carcinoma
Transitional Cell/*drug therapy/mortality/pathology
Disease Progression
Electrochemotherapy/adverse effects/*methods
Humans
Mitomycin/*administration & dosage
Neoplasm Recurrence
Local
Randomized Controlled Trials as Topic
Time Factors
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
文献简介
原文链接
Gemcitabine/cisplatin versus methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive bladder cancer: A systematic review and meta-analysis
2018 年 发布于
Urol Oncol
286 卷 第 22 期
Yu C.
Hequn C.
Jinbo C.
Feng Z.
Xiongbing Z.
Jian D.
Administration
Intravesical
Aged
Aged
80 and over
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage/adverse
effects
BCG Vaccine/administration & dosage
Bayes Theorem
Deoxycytidine/administration & dosage/analogs & derivatives
Disease Progression
Epirubicin/administration & dosage
Female
Humans
Isoniazid/administration & dosage
Male
Middle Aged
Mitomycin/administration & dosage
Neoplasm Invasiveness
Neoplasm Recurrence
Local
Odds Ratio
Randomized Controlled Trials as Topic
Risk Factors
Time Factors
Treatment Outcome
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
Gemcitabine
efficacy and safety
intravesical therapy
non-muscle invasive bladder cancer
tumor progression
tumor recurrence
文献简介
原文链接
Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis
2018 年 发布于
Oncotarget
11 卷 第 11 期
Yan H.
Ying Y.
Xie H.
Li J.
Wang X.
He L.
Jin K.
Tang J.
Xu X.
Zheng X.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemotherapy
Adjuvant
Cisplatin/administration & dosage
Humans
Neoadjuvant Therapy
Neoplasm Invasiveness
Urinary Bladder Neoplasms/*drug therapy/mortality/pathology
Bladder cancer
Chemotherapy
Neoadjuvant
Platinum
Survival
article.
文献简介
原文链接